GUEST PRESIDENT Dr. Kingsley R Chin at the 32nd Annual Meeting of the Korea Society of Neurosurgery of Custics in Seoul (Ksns), the founder and CEO of Kic Ventures reveals a global vision to transform column surgery.
Fort Lauderdale, Florida, September 30, 2025 / PRNewswire / -A measure that the spine industry continues to double on rigid fixation and the procedures promoted by the hospital, the orthopedic column surgeon, the teacher and the CEO of Kic Ventures, Dr. Kingsley R. Chin, it stands out for having been a different course of the years before. At its 2018 opening at the 32nd Annual Meeting of the Korean Society of Neurosurgery Spinal (KSNS), Dr. Chin issued a bold and prophetic call for change. Speaking at an international stage in Busan, South Korea, a future predicted in which the movement preservation technologies and the column column surgery techniques (less ™) would take care of the spine of hospitals and in outpatient environments.
Calling the fusion paradigm
In 2018, Dr. Chin highlighted how decades of dependency driven by the pedicular screw industry and interboderate cages had resulted in high -risk expensive hospital procedures without significantly improving long -term results. He argued that rigid fixation was an obsolete model, dominated by hospitals and innovation resistant. On the other hand, he defended a new era in which technologies are designed to preserve movement, respect the anatomy and move the attention of hospitals to the centers of outpatient surgery, the basis of the Rep of Kic Ventures Republic: restore the function, early treatment, the anatomy of preservation.
“The fusion model (brain screws, cages and rigid fixation) is patients who fail and suffocate innovation,” said Dr. Chin in his direction. “The future belongs to movement preservation devices delivered with fewer exposure column surgery techniques in outpatient environments.”
Evidence of a market change
Since the key note of Dr. Chin 2018, his warnings have become reality. Several important players have left or restructured their column divisions, including Zimmer Biomet, Nuvasive and Stryker. Market limits for leading companies such as Orthofix and Globus Medical have also decreased since traditional fusion models face growing scrutiny. These market changes underline the validity of Dr. Chin’s prediction that rigid fixation and hospital -centered approaches would fight to maintain growth.
Why Medtech investors should listen
While many Medtech investors focus closely on short -term income objectives and quarterly metrics, Kic Ventures has constantly observed where the market is directed. The key note of Dr. Chin 2018 was not only a prediction, but a road map. Five years later, that road map is developing exactly how it is forecast. By relying on the proven capacity of Kic Ventures to anticipate and shape the changes in the industry, from the preservation of the movement to the column surgery of less exposure, investors can participate in the creation of completely new categories instead of simply seeing the old people reducing.
The vision: preservation of movement, the principles of representative and the Less ™ philosophy
In the center of Dr. Chin’s key note was the Axiomed Total Viscoelastic Disc replacement, a movement preservation device based on the REP principles and Less ™ philosophy. Together with the Nanism ™ platform, the Kic Ventures platform offered by differentiated technologies such as INSPAN ™, Sacrix ™ and Facetfuse ™ for the exposure stabilization and decompression of LESS ™ exposure in ASC, these technologies incorporate the company’s strategy to create a complete spectrum of motorcycle presentation and column solutions less exposure backed by global clinical evidence. Nanofuse® complements this portfolio as the company of synthetic biological and regenerative column of the company.
Acting on prediction
Kic Ventures has acted decisively in the vision of Dr. Chin by advancing in the axiomed movement preservation technology, expanding Nanism ™ solutions for outpatient stabilization and decompression, and defending the spine column surgery movement less exposure. Beyond the replacement of the album, Kic Ventures is opening new markets in the management of interventionist pain and invests in the creation of a new specialty of intervention column column surgery, redefining how care of the spine worldwide is provided worldwide and offers investors a rare opportunity to participate in the construction of these new categories from the ground.
Global impulse
In 2024, Kic Ventures attended Eurospine in Austria, where the company showed Axiomed technologies and deepened relations with European partners. This year, Kic Ventures will participate in Eurospine Copenhagen, reinforcing its global footprint and leadership in spine solutions. The surgeon’s validation continues to grow internationally: the Cervical and Lumbar Discs of Axiomed have been validated by the main surgeons in Australia.
Global commitment in ksns
Dr. Chin’s speech in Ksns caused a significant interest between Korean neurosurgeons and surgeons in the orthopedic column eager to explore how technologies that preserve movement could raise the results of patients. The main note also stressed the importance of international collaboration to accelerate the transition from hospital -centered fusion to the preservation of outpatient movement.
“What we discussed in Busan was a turning point: we were showing the world that column surgery does not have to be based on the hospital and depend on obsolete fixing technologies,” reflected Dr. Chin. “We could see the future to develop.”
A personal and professional milestone
For Dr. Chin, who was born and grew up in Buff Bay, Jamaica, the key note represented the culmination of years of dedication to advance in the column of placement of less exposure and the care of the spine:
“It is leaving in Busan as a teacher, surgeon and CEO, presenting a vision for the replacement of outpatient discs as a successor to traditional fusion, it was deeply humble,” he said. “Our belief confirmed that column surgery must evolve.”
Looking towards the future: a vision that endures
Years later, Dr. Chin’s predictions in KSN are still surprisingly presumed as the column field continues its pivot towards outpatient care technologies and movement preservation using column column surgery techniques less exposure. Its main opening of 2018 stands as an early marker of this global change, which shows that the departure from traditional fusion towards the replacement of the album in outpatient environments was not only possible but inevitable.
About Kic Ventures
Founded in 2013 as the risk arm of Kingsley Investment Company (KIC) LLC, Kic Ventures focuses exclusively on advancing in outpatient column surgery through its philosophy of column column surgery of less exposure (less ™). With an innovative column technologies portfolio and a commitment to empower doctors, Kic Ventures has become the world’s largest private capital company with a portfolio of differentiated column companies focused on outpatient column solutions.
Kic Ventures source
